These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 10887276

  • 1. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J, Kerr C, Teo K.
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract] [Full Text] [Related]

  • 2. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 3. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C, Yan GX, Kocovic D, Kowey PR.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract] [Full Text] [Related]

  • 4. The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.
    Green MS, Ricci J, Wolfe K.
    Can J Cardiol; 2000 Jun; 16 Suppl C():13C-5C. PubMed ID: 10887271
    [No Abstract] [Full Text] [Related]

  • 5. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 6. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ, Krahn A, Klein G.
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D, Breithardt G.
    Am J Cardiol; 1999 Mar 11; 83(5B):83D-87D. PubMed ID: 10089846
    [Abstract] [Full Text] [Related]

  • 8. The management of acute ventricular tachycardia or fibrillation.
    Dorian P, Philippon F.
    Can J Cardiol; 2000 Jun 11; 16 Suppl C():16C-9C. PubMed ID: 10887272
    [No Abstract] [Full Text] [Related]

  • 9. Randomized clinical trials: how long should they last?
    Wellens HJ.
    Circulation; 2004 Jul 13; 110(2):107-8. PubMed ID: 15249514
    [No Abstract] [Full Text] [Related]

  • 10. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2001 Jul 13; 2(4):197-205. PubMed ID: 12439369
    [Abstract] [Full Text] [Related]

  • 11. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME.
    Nat Clin Pract Cardiovasc Med; 2006 Mar 13; 3(3):115. PubMed ID: 16505838
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of sudden death from ventricular arrhythmia. Epidemiology.
    Gardner MJ, Leather R, Teo K.
    Can J Cardiol; 2000 Jun 13; 16 Suppl C():10C-2C. PubMed ID: 10887270
    [No Abstract] [Full Text] [Related]

  • 13. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP.
    J Cardiovasc Electrophysiol; 2010 Sep 13; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract] [Full Text] [Related]

  • 14. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
    Ye S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD.
    Circulation; 2011 Jun 14; 123(23):2674-80. PubMed ID: 21606398
    [Abstract] [Full Text] [Related]

  • 15. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
    Doherty JU, Fuchs S, Tecce MA.
    Geriatrics; 2000 Aug 14; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
    [Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic therapy in heart failure.
    Eckardt L, Haverkamp W, Breithardt G.
    Heart Fail Monit; 2002 Aug 14; 2(4):110-9. PubMed ID: 12634885
    [Abstract] [Full Text] [Related]

  • 17. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J, Niehaus M, Korte T.
    Dtsch Med Wochenschr; 2002 Oct 11; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract] [Full Text] [Related]

  • 18. [Prevention of sudden (rhythm-induced) cardiac death].
    Andresen D, Behrens S, Arntz R, Brüggemann T.
    Internist (Berl); 1993 May 11; 34(5):423-35. PubMed ID: 8509253
    [No Abstract] [Full Text] [Related]

  • 19. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R.
    Am J Cardiol; 1999 Mar 11; 83(5B):68D-73D. PubMed ID: 10089843
    [Abstract] [Full Text] [Related]

  • 20. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
    Disertori M, Dallafior D, Marini M.
    Ital Heart J Suppl; 2001 Dec 11; 2(12):1265-9. PubMed ID: 11838346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.